This topic contains a solution. Click here to go to the answer

Author Question: Why is the patient on Coumadin therapy? What will be an ideal ... (Read 12 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
Why is the patient on Coumadin therapy?
 
  What will be an ideal response?

Question 2

List five of the patient's cardiovascular risk factors.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

The patient is taking Coumadin for a history of deep venous thrombosis and pulmonary embolism.

Answer to Question 2

Type 2 diabetes mellitus, hypertension, dyslipidemia, family history of premature coronary artery disease, overweight, physical inactivity
Note, six are listed here; the student only needs to answer with five.



corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
Correct answers!



coreycathey

  • Sr. Member
  • ****
  • Posts: 333
Great! Please up vote :D



 

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library